Metabolomic Profiles Are Gender, Disease and Time Specific in the Interleukin-10 Gene-Deficient Mouse Model of Inflammatory Bowel Disease

PLoS ONE

Volumn 8, Issue 7, 2013, Pages

  Tso, Victor K ^a   Sydora, Beate C ^a   Foshaug, Rae R ^a   Churchill, Thomas A ^a   Doyle, Jason ^b   Slupsky, Carolyn M ^c   Fedorak, Richard N ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

^b Vernon Jubilee Hospital   (Canada)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 10;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; CROHN DISEASE; DISEASE ACTIVITY; DISEASE SEVERITY; ENTERITIS; FEMALE; HISTOPATHOLOGY; IMMUNE RESPONSE; MALE; METABOLOMICS; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; SEX DIFFERENCE; SPECTROSCOPY; ULCERATIVE COLITIS; URINALYSIS; WILD TYPE;

AGE FACTORS; ANIMALS; DISEASE MODELS, ANIMAL; FEMALE; INFLAMMATORY BOWEL DISEASES; INTERLEUKIN-10; MALE; METABOLOME; METABOLOMICS; MICE; SEX FACTORS;

MUS;

EID: 84879901141     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0067654     Document Type: Article

References (43)

1. Bollard ME, Stanley EG, Lindon JC, Nicholson JK, Holmes E, (2005) NMR-based metabonomic approaches for evaluating physiological influences on biofluid composition. NMR Biomed 18: 143-162.
2. Lindon JC, Holmes E, Bollard ME, Stanley EG, Nicholson JK, (2004) Metabonomics technologies and their applications in physiological monitoring, drug safety assessment and disease diagnosis. Biomarkers 9: 1-31.
3. Bamias G, Cominelli F, (2007) Immunopathogenesis of inflammatory bowel disease: current concepts. Curr Opin Gastroenterol 23: 365-369.
4. Sartor RB (1997) Review article: Role of the enteric microflora in the pathogenesis of intestinal inflammation and arthritis. Aliment Pharmacol Ther 11 Suppl 3: 17-22; discussion 22-13.
5. Sherman MA, Kalman D, (2004) Initiation and resolution of mucosal inflammation. Immunol Res 29: 241-252.
6. Chichlowski M, Hale LP, (2008) Bacterial-mucosal interactions in inflammatory bowel disease: an alliance gone bad. Am J Physiol Gastrointest Liver Physiol 295: G1139-1149.
7. Marchesi JR, Holmes E, Khan F, Kochhar S, Scanlan P, et al. (2007) Rapid and noninvasive metabonomic characterization of inflammatory bowel disease. J Proteome Res 6: 546-551.
8. Bjerrum JT, Nielsen OH, Hao F, Tang H, Nicholson JK, et al. (2010) Metabonomics in ulcerative colitis: diagnostics, biomarker identification, and insight into the pathophysiology. J Proteome Res 9: 954-962.
9. Williams HR, Cox IJ, Walker DG, Cobbold JF, Taylor-Robinson SD, et al. (2010) Differences in gut microbial metabolism are responsible for reduced hippurate synthesis in Crohn's disease. BMC Gastroenterol 10: 108.
10. Zelinkova Z, Bultman E, Vogelaar L, Bouziane C, Kuipers EJ, et al. (2012) Sex-dimorphic adverse drug reactions to immune suppressive agents in inflammatory bowel disease. World J Gastroenterol 18: 6967-6973.
11. Murdoch TB, Fu H, MacFarlane S, Sydora BC, Fedorak RN, et al. (2008) Urinary metabolic profiles of inflammatory bowel disease in interleukin-10 gene-deficient mice. Anal Chem 80: 5524-5531.
12. Martin FP, Rezzi S, Philippe D, Tornier L, Messlik A, et al. (2009) Metabolic assessment of gradual development of moderate experimental colitis in IL-10 deficient mice. J Proteome Res 8: 2376-2387.
13. Chen C, Shah YM, Morimura K, Krausz KW, Miyazaki M, et al. (2008) Metabolomics reveals that hepatic stearoyl-CoA desaturase 1 downregulation exacerbates inflammation and acute colitis. Cell Metab 7: 135-147.
14. Schicho R, Nazyrova A, Shaykhutdinov R, Duggan G, Vogel HJ, et al. (2010) Quantitative metabolomic profiling of serum and urine in DSS-induced ulcerative colitis of mice by (1)H NMR spectroscopy. J Proteome Res 9: 6265-6273.
15. Otter D, Cao M, Lin HM, Fraser K, Edmunds S, et al. (2011) Identification of urinary biomarkers of colon inflammation in IL10-/- mice using Short-Column LCMS metabolomics. J Biomed Biotechnol 2011: 974701.
16. Qiao Q, Li T, Sun J, Liu X, Ren J, et al. (2011) Metabolomic analysis of normal (C57BL/6J, 129S1/SvImJ) mice by gas chromatography-mass spectrometry: detection of strain and gender differences. Talanta 85: 718-724.
17. Moleski SM, Choudhary C (2011) Special considerations for women with IBD. Gastroenterol Clin North Am 40: 387-398, viii-ix.
18. Blumenstein I, Herrmann E, Filmann N, Zosel C, Tacke W, et al. (2011) Female patients suffering from inflammatory bowel diseases are treated less frequently with immunosuppressive medication and have a higher disease activity: a subgroup analysis of a large multi-centre, prospective, internet-based study. J Crohns Colitis 5: 203-210.
19. Sridhar AR, Parasa S, Navaneethan U, Crowell MD, Olden K, (2011) Comprehensive study of cardiovascular morbidity in hospitalized inflammatory bowel disease patients. J Crohns Colitis 5: 287-294.
20. Peyrin-Biroulet L, Pillot C, Oussalah A, Billioud V, Aissa N,et al. Urinary tract infections in hospitalized inflammatory bowel disease patients: A 10-year experience. Inflamm Bowel Dis.
21. Malickova K, Duricova D, Bortlik M, Hruskova Z, Svobodova B, et al. (2011) Impaired deoxyribonuclease I activity in patients with inflammatory bowel diseases. Autoimmune Dis 2011: 945861.
22. Lee GJ, Kappelman MD, Boyle B, Colletti RB, King E, et al. (2012) Role of sex in the treatment and clinical outcomes of pediatric patients with inflammatory bowel disease. J Pediatr Gastroenterol Nutr 55: 701-706.
23. Fernandes MT, Ferraro AA, de Azevedo RA, Fagundes Neto U, (2010) Metabolic differences between male and female adolescents with non-alcoholic fatty liver disease, as detected by ultrasound. Acta Paediatr 99: 1218-1223.
24. McCombe PA, Greer JM, Mackay IR, (2009) Sexual dimorphism in autoimmune disease. Curr Mol Med 9: 1058-1079.
25. Zandman-Goddard G, Peeva E, Shoenfeld Y, (2007) Gender and autoimmunity. Autoimmun Rev 6: 366-372.
26. Gleicher N, Barad DH, (2007) Gender as risk factor for autoimmune diseases. J Autoimmun 28: 1-6.
27. Ghazeeri G, Abdullah L, Abbas O, (2011) Immunological differences in women compared with men: overview and contributing factors. Am J Reprod Immunol 66: 163-169.
28. Duma D, Collins JB, Chou JW, Cidlowski JA, (2010) Sexually dimorphic actions of glucocorticoids provide a link to inflammatory diseases with gender differences in prevalence. Sci Signal 3: ra74.
29. Alvarado CM, Diaz JA, Hawley AE, Wrobleski SK, Sigler RE, et al. (2011) Male mice have increased thrombotic potential: sex differences in a mouse model of venous thrombosis. Thromb Res 127: 478-486.
30. Chrousos GP, (2010) Stress and sex versus immunity and inflammation. Sci Signal 3: pe36.
31. Looijer-van Langen M, Hotte N, Dieleman LA, Albert E, Mulder C, et al. (2011) Estrogen receptor-beta signaling modulates epithelial barrier function. Am J Physiol Gastrointest Liver Physiol 300: G621-626.
32. Morris ME, Lee HJ, Predko LM, (2003) Gender differences in the membrane transport of endogenous and exogenous compounds. Pharmacol Rev 55: 229-240.
33. Blaak E, (2001) Gender differences in fat metabolism. Curr Opin Clin Nutr Metab Care 4: 499-502.
34. Wu BN, O'Sullivan AJ, (2011) Sex differences in energy metabolism need to be considered with lifestyle modifications in humans. J Nutr Metab 2011: 391809.
35. Tarnopolsky MA, (2000) Gender differences in metabolism; nutrition and supplements. J Sci Med Sport 3: 287-298.
36. Tarnopolsky MA, Ruby BC, (2001) Sex differences in carbohydrate metabolism. Curr Opin Clin Nutr Metab Care 4: 521-526.
37. Mittendorfer B, Horowitz JF, Klein S, (2002) Effect of gender on lipid kinetics during endurance exercise of moderate intensity in untrained subjects. Am J Physiol Endocrinol Metab 283: E58-65.
38. Stanley EG, Bailey NJ, Bollard ME, Haselden JN, Waterfield CJ, et al. (2005) Sexual dimorphism in urinary metabolite profiles of Han Wistar rats revealed by nuclear-magnetic-resonance-based metabonomics. Anal Biochem 343: 195-202.
39. Sydora BC, Tavernini MM, Wessler A, Jewell LD, Fedorak RN, (2003) Lack of interleukin-10 leads to intestinal inflammation, independent of the time at which luminal microbial colonization occurs. Inflamm Bowel Dis 9: 87-97.
40. Kuhn R, Lohler J, Rennick D, Rajewsky K, Muller W, (1993) Interleukin-10-deficient mice develop chronic enterocolitis. Cell 75: 263-274.
41. Williams HR, Cox IJ, Walker DG, North BV, Patel VM, et al. (2009) Characterization of inflammatory bowel disease with urinary metabolic profiling. Am J Gastroenterol 104: 1435-1444.
42. Turner MW, (1996) Mannose-binding lectin: the pluripotent molecule of the innate immune system. Immunol Today 17: 532-540.
43. Mittelstrass K, Ried JS, Yu Z, Krumsiek J, Gieger C, et al. (2011) Discovery of sexual dimorphisms in metabolic and genetic biomarkers. PLoS Genet 7: e1002215.